Edwards Lifesciences Corp. (EW)
90.79
+0.05
(+0.06%)
USD |
NYSE |
Sep 02, 16:00
90.79
0.00 (0.00%)
After-Hours: 16:37
Edwards Lifesciences Cash from Investing (Quarterly) : -193.20M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -193.20M |
| March 31, 2026 | -92.80M |
| December 31, 2025 | -198.30M |
| September 30, 2025 | -661.50M |
| June 30, 2025 | -172.10M |
| March 31, 2025 | 85.30M |
| December 31, 2024 | -576.70M |
| September 30, 2024 | 2.702B |
| June 30, 2024 | 124.80M |
| March 31, 2024 | 63.10M |
| December 31, 2023 | 14.10M |
| September 30, 2023 | 89.00M |
| June 30, 2023 | 70.20M |
| March 31, 2023 | 0.50M |
| December 31, 2022 | 94.70M |
| September 30, 2022 | -201.50M |
| June 30, 2022 | 129.60M |
| March 31, 2022 | 229.50M |
| December 31, 2021 | -965.90M |
| September 30, 2021 | -377.40M |
| June 30, 2021 | -329.50M |
| March 31, 2021 | -49.70M |
| December 31, 2020 | -259.90M |
| September 30, 2020 | -126.30M |
| June 30, 2020 | -10.20M |
| Date | Value |
|---|---|
| March 31, 2020 | -134.70M |
| December 31, 2019 | -445.30M |
| September 30, 2019 | -12.70M |
| June 30, 2019 | -88.30M |
| March 31, 2019 | -49.50M |
| December 31, 2018 | 5.70M |
| September 30, 2018 | -254.20M |
| June 30, 2018 | 104.90M |
| March 31, 2018 | 220.30M |
| December 31, 2017 | 49.30M |
| September 30, 2017 | -209.50M |
| June 30, 2017 | -638.20M |
| March 31, 2017 | 151.20M |
| December 31, 2016 | 80.20M |
| September 30, 2016 | 3.90M |
| June 30, 2016 | -343.10M |
| March 31, 2016 | 47.30M |
| December 31, 2015 | 27.30M |
| September 30, 2015 | -175.60M |
| June 30, 2015 | 12.50M |
| March 31, 2015 | -180.30M |
| December 31, 2014 | 112.00M |
| September 30, 2014 | -154.80M |
| June 30, 2014 | -470.40M |
| March 31, 2014 | -119.80M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp. | -639.00M |
| Intuitive Surgical, Inc. | -26.60M |
| Abbott Laboratories | -673.00M |
| Zimmer Biomet Holdings, Inc. | -190.80M |
| Solventum Corp. | -87.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 651.90M |
| Cash from Financing (Quarterly) | -0.30M |
| Free Cash Flow | 1.434B |
| Free Cash Flow Per Share (Quarterly) | 1.013 |
| Free Cash Flow to Equity (Quarterly) | 583.50M |
| Free Cash Flow to Firm (Quarterly) | 585.00M |
| Free Cash Flow Yield | 2.72% |